在药房招生途径中评估多次微型面试表现
Daniel L Friesner1, Alyssa Preheim1, Libby Wirth1
1School of Pharmacy and College of Health Professions, North Dakota State University, Fargo, ND, USA.
American journal of pharmaceutical education
|June 19, 2023
概括
通过早期保证途径申请药学博士课程的申请人表现出与其他招生途径相比,通过多次微型面试 (MMI) 评分测量的类似情感能力. 这表明,不同的招生策略不会影响候选人的关键特征.
科学领域:
- 药房 教育 教育 药房 教育
- 医学院招生录取 医学院招生录取
- 能力评估能力评估能力评估能力评估能力
背景情况:
- 药学博士课程利用各种招生途径,包括早期保证和传统路线.
- 评估情感领域能力对于选择成功的药学学生至关重要.
- 多个小面试 (MMI) 是评估招生中非认知技能的常见工具.
研究的目的:
- 为了确定早期保证 (EA) 药学博士课程的入学途径是否与其他入学途径相比,产生不同情感领域能力的学生.
- 分析EA和非EA申请人之间的多次小面试 (MMI) 分数的差异.
主要方法:
- 从美国药学院的三个招生周期中对现有数据的二次分析.
- 早期保证和其他入学途径申请人之间的MMI分数 (总和个别问题) 的比较.
- 使用克鲁斯卡尔-瓦利斯测试来确定显著差异的统计分析.
主要成果:
- 在早期保证和所有周期的其他入学途径申请人之间,在MMI总得分上没有发现统计学上显著的差异.
- 在特定的周期中,早期保证申请者在某些MMI项目中表现出显著的差异,例如在一个周期中,在责任方面得分较低,在交叉项目上得分更高,在另一个周期中,在自我意识方面得分更高.
- 这些项目特定的差异在所有招生周期中都不一致.
结论:
- 通过早期保证途径被录取的药学博士申请人,根据MMI评估,表现出与通过其他途径被录取的人相似的情感领域能力.
- MMI是评估情感能力的一个有价值的工具,研究结果表明,不同的招生途径并不固有地为这些特征的不同水平进行选择.
- 未来的研究可以探索其他因素影响药学学生通过不同的途径录取的情感能力.
相关概念视频
Three-Compartment Open Model
291
The three-compartment open model is a pharmacokinetic model used to describe the distribution and elimination of drugs following extravascular administration. It comprises a central compartment representing the plasma and two peripheral compartments. The highly perfused peripheral compartment represents organs and tissues with a rich blood supply, such as the liver, kidneys, and lungs. The scarcely perfused peripheral compartment represents tissues with lower blood supply, such as adipose...
291
Analysis of Population Pharmacokinetic Data
306
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
306
Drug Administration and Therapy Phases: Overview
562
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
562
Biopharmaceutics and Pharmacokinetics: Overview
2.2K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.2K
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
185
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
185
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
99
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
99


